Related references
Note: Only part of the references are listed.Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study
Thomas Danne et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Glycaemic efficacy and safety of mealtime faster-acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta-analysis of randomized controlled trials
Rimesh Pal et al.
DIABETIC MEDICINE (2021)
The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications
David R. Owens et al.
DIABETES OBESITY & METABOLISM (2020)
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit
Harshal Deshmukh et al.
DIABETES CARE (2020)
Towards a better understanding of postprandial hyperglycemic episodes in people with diabetes: impact on daily functioning
Simon Heller et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Thomas Danne et al.
DIABETES CARE (2019)
Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
Jonas Kildegaard et al.
PHARMACEUTICAL RESEARCH (2019)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Roy W. Beck et al.
DIABETES CARE (2019)
Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests
Timothy C. Dunn et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
Jingyi Lu et al.
DIABETES CARE (2018)
Optimal prandial timing of bolus insulin in diabetes management: a review
D. Slattery et al.
DIABETIC MEDICINE (2018)
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes) A multicenter retrospective nationwide Italian study and crowdsourcing opportunity
G. P. Fadini et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)
Targeting One-Hour Postmeal Glucose: Is It Time for a Paradigm Switch in Diabetes Management?
Antonio Ceriello
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)
David Russell-Jones et al.
DIABETES CARE (2017)
Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target
Paolo Rossetti et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes
Tim Heise et al.
CLINICAL PHARMACOKINETICS (2017)
Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
Sten Madsbad
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA
Meryl Brod et al.
DIABETES THERAPY (2016)
The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries
Meryl Brod et al.
DIABETES THERAPY (2016)
Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA
Meryl Brod et al.
DIABETES THERAPY (2016)
The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries
Meryl Brod et al.
DIABETES THERAPY (2016)
Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials
R. A. DeFronzo et al.
DIABETIC MEDICINE (2010)
Share Paper
